IsoRay Inc Investor Relations Material
Isoray, Inc. develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers its products for the treatment of prostate cancer and conditions in the brain; underactive thyroid; eye disorders related to the retina, including diabetic retinopathy, retinal vein occlusion, wet age-related macular degeneration, and retinitis pigmentosa; lung cancer; liver cancer; lymphoma/leukemia
Latest company events
Ticker symbol
ISR
Country
United States of America
About the company
Investor Relations Page
Dig deeper into the IsoRay Inc fundamentals on Quartr.
- Skip straight to the Q&A session
- Receive notifications about new events
- Connect the financial calender on your phone
- Figure out why the stock is up or down
- Read the transcripts or scroll the deck
- Access earnings or press releases
